OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer
Moumita Kundu, Ramesh Butti, Venketesh K. Panda, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Myeloid cell-derived apCAFs promote HNSCC progression by regulating proportion of CD4+ and CD8+ T cells
Feilong Ren, Lin Meng, Shize Zheng, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 2

Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer
Shan Liu, Xingda Zhang, Wenzheng Wang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13

Oral Cancer Stem Cells: A Comprehensive Review of Key Drivers of Treatment Resistance and Tumor Recurrence
P J Nagarathna, Santosh Patil, Vishnu Priya Veeraraghavan, et al.
European Journal of Pharmacology (2025), pp. 177222-177222
Closed Access | Times Cited: 1

Golgi protein 73: the driver of inflammation in the immune and tumor microenvironment
Pingping Feng, Xinyang Hu, Sining Zhou, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1

Molecular Insights on Signaling Cascades in Breast Cancer: A Comprehensive Review
Venketesh K. Panda, Barnalee Mishra, Samikshya Mahapatra, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 234-234
Open Access | Times Cited: 1

The combination of flaxseed lignans and PD-1/ PD-L1 inhibitor inhibits breast cancer growth via modulating gut microbiome and host immunity
Hao Wu, J.F. Liu, Xinghua Zhang, et al.
Drug Resistance Updates (2025) Vol. 80, pp. 101222-101222
Open Access | Times Cited: 1

The axis of tumor-associated macrophages, extracellular matrix proteins, and cancer-associated fibroblasts in oncogenesis
Shu‐Hong Yu, Siyu Wang, Xuanyu Wang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5

Parishin B blocking TRIB3-AKT1 interaction inhibits breast cancer lung metastasis
Xiongtao Cheng, Jianguo Sun, Shouhong Chen, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access

The construction of a breast cancer prognostic model by combining genes related to hypoxia and endoplasmic reticulum stress
Guohua Liu, Yuan Shi, Jing Wang, et al.
Computer Methods in Biomechanics & Biomedical Engineering (2025), pp. 1-14
Closed Access

Platinum(IV) Complexes Trigger Death Receptors and Natural Killer Cells to Suppress Breast Cancer
Linxiang Cai, Hanhua Chen, Ying Wang, et al.
Journal of Medicinal Chemistry (2025)
Closed Access

Comprehensive characterization of fatty acid oxidation in triple-negative breast cancer: Focus on biological roles and drug modulation
Yunduo Liu, Yanxia Zhang, Qin Xiang, et al.
European Journal of Pharmacology (2025), pp. 177343-177343
Closed Access

Towards understanding cancer dormancy over strategic hitching up mechanisms to technologies
Sumin Yang, Jieun Seo, Jeong‐Hyeon Choi, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access

Targeting the Tumor Microenvironment in EGFR-Mutant Lung Cancer: Opportunities and Challenges
Jeong Uk Lim, Junyang Jung, Yeon Wook Kim, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 470-470
Open Access

The novel ginseng Rh2 derivative 2-Deoxy-Rh2, exhibits potent anticancer effect via the AMPK/mTOR/autophagy signaling pathway against breast cancer
Xiaodong Li, Jianyuan Yin, Qing Song, et al.
Chemico-Biological Interactions (2025) Vol. 409, pp. 111422-111422
Closed Access

Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment
Mengting Wan, Shuaikang Pan, Benjie Shan, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access

Translational Advances in Oncogene and Tumor-Suppressor Gene Research
Radoslav Stojchevski, Edward Agus Sutanto, R. Sutanto, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 1008-1008
Open Access

Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance
Tongxuan Shang, Ziqi Jia, J. Li, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access

CircRNAs: a novel potential strategy to treat breast cancer
Pangzhou Chen, Jinhui Zhang, Song Wu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

CD47 Contributes to the Proliferation of Breast Cancer
Junbin Wang, Xia Wu, Xuejian Liu, et al.
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 3
Open Access

Page 1 - Next Page

Scroll to top